The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts.
Wiemer
G
G
Hoechst AG, Frankfurt am Main, Germany.
Schölkens
B A
BA
Wagner
A
A
Heitsch
H
H
Linz
W
W
D000804:Angiotensin II / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001920:Bradykinin / Q000031:analogs & derivatives / Q000494:pharmacology; D002417:Cattle; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism*; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D017202:Myocardial Ischemia / Q000378:metabolism*; D009569:Nitric Oxide / Q000096:biosynthesis; D019335:Nitroarginine; D009842:Oligopeptides / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011945:Receptors, Angiotensin / Q000145:classification / Q000378:metabolism*
D057911:Angiotensin Receptor Antagonists; D009842:Oligopeptides; D011945:Receptors, Angiotensin; D000804:Angiotensin II; C060894:CGP 42112A; D019335:Nitroarginine; D009569:Nitric Oxide; C065679:icatibant; D001120:Arginine; D006152:Cyclic GMP; D001920:Bradykinin